FULC Latest Headlines

Fulcrum Therapeutics Charts Pivotal Path After Earnings Call

at www.tipranks.com (Sun, 1-Mar 7:14 PM)

RBC Capital Remains a Hold on Fulcrum Therapeutics (FULC)

at www.tipranks.com (Wed, 25-Feb 7:41 AM)

Analysts Offer Insights on Healthcare Companies: Alpha Cognition Inc (ACOG) and Fulcrum Therapeutics (FULC)

at www.tipranks.com (Wed, 25-Feb 6:30 AM)

Fulcrum’s Positive 20 mg Pociredir Data Positions Company for Registration Trial and Extends Cash Runway into 2029

Market Chameleon (Tue, 24-Feb 7:31 AM)

Fulcrum Therapeutics Awards 70,000-Share Inducement Option at $10.72: What Does This Mean for Investors?

Market Chameleon (Mon, 9-Feb 7:11 AM)

FULC’s $150 Million Public Offering Targets R&D and Growth—Will Expanded Funding Accelerate Innovation?

Market Chameleon (Tue, 9-Dec 8:39 AM)

Inducement Stock Options Grant Highlights Fulcrum Therapeutics’ Talent Strategy as Shares Surge

Market Chameleon (Mon, 8-Dec 9:54 AM)